Galectin-8 up-regulation during hypopharyngeal and laryngeal tumor progression and comparison with galectin-1, -3 and -7

Anticancer Research

Volumn 29, Issue 12, 2009, Pages 4933-4940

  Cludts, Stéphanie ^a   Decaestecker, Christine ^b,f   Mahillon, Virginie ^b   Chevalier, Dominique ^c   Kaltner, Herbert ^d   André, Sabine ^d   Remmelink, Myriam ^b,e   Leroy, Xavier ^c   Gabius, Hans Joachim ^d   Saussez, Sven ^a,b  

^a UNIVERSITY OF MONS   (Belgium)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^c LILLE UNIVERSITY HOSPITAL   (France)

^d UNIVERSITY OF MUNICH   (Germany)

^e ERASME HOSPITAL   (Belgium)

^f FNRS   (Belgium)

Author keywords

Dysplasia; Epithelium; Galectin 8; Lectin; Malignancy; Preneoplasia

Indexed keywords

GALECTIN 1; GALECTIN 3; GALECTIN 7; GALECTIN 8;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CONTROLLED STUDY; EPITHELIUM DYSPLASIA; FEMALE; HUMAN; HUMAN TISSUE; HYPOPHARYNX CARCINOMA; HYPOPHARYNX TUMOR; LABELING INDEX; LARYNX CARCINOMA; LARYNX TUMOR; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GALECTIN 1; GALECTIN 3; GALECTINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOPHARYNGEAL NEOPLASMS; IMMUNOENZYME TECHNIQUES; LARYNGEAL NEOPLASMS; LARYNX; MALE; MIDDLE AGED; NEOPLASM STAGING; PHARYNX; PROGNOSIS; RABBITS; RETROSPECTIVE STUDIES; UP-REGULATION;

EID: 75149122376     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Gabius H-J (ed.). The Sugar Code. Fundamentals of Glycosciences. Weinheim, Germany: Wiley-VCH, 2009.
2. Patsos G, André S, Roeckel N, Gromes R, Gebert J, Kopitz J and Gabius HJ: Compensation of loss of protein function in microsatellite-unstable colon cancer cells (HCTl 16): a gene-dependent effect on cell surface glycan profile. Glycobiology 7: 726-34, 2009.
3. INK4a - modulator of glycomic profile and galectin-1 expression to increase susceptibility to carbohydrate-dependent induction of anoikis in pancreatic carcinoma cells. FEBS J 274: 3233-3256, 2007.
4. Arbel-Goren R, Levy Y, Ronen D and Zick Y: Cyclin-dependent kinase inhibitors and JNK act as molecular switches, regulating the choice between growth arrest and apoptosis induced by galectin-8. J Biol Chem 280: 19105-19114, 2005.
5. Fischer C, Sanchez-Ruderisch H, Welzel M, Wiedenmann B, Sakai T, André S, Gabius HJ, Khachigian L, Detjen KM and Rosewicz S: Galectin-1 interacts with the α5β1 fibronectin receptor to restrict carcinoma cell growth via induction of p21 and p27. J Biol Chem 280: 37266-37277, 2005.
6. Saussez S, Cucu D-R, Decaestecker C, Chevalier D, Kaltner H, André S, Wacreniez A, Toubeau G, Camby I, Gabius HJ and Kiss R: Galectin-7 (p53-induced gene 1): a new prognostic predictor of recurrence and survival in stage IV hypopharyngeal cancer. Ann Surg Oncol 13: 999-1009, 2006.
7. Saussez S, Decaestecker C, Lorfevre F, Cucu DR, Mortuaire G, Chevalier D, Wacreniez A, Kaltner H, André S, Toubeau G, Camby I, Gabius HJ and Kiss R: High level of galectin 1 expression is a negative prognostic predictor of recurrence in laryngeal squamous cell carcinomas. Int J Oncol 30: 1109-1117, 2007.
8. Saussez S, Decaestecker C, Lorfevre F, Chevalier D, Mortuaire G, Kaltner H, André S, Toubeau G, Gabius HJ and Leroy X: Increased expression and altered intracellular distribution of adhesion/growth-regulatory lectins galectins-1 and -7 during tumour progression in hypopharyngeal and laryngeal squamous cell carcinomas. Histopathology 52: 483-493, 2008.
9. Saussez S, Decaestecker C, Cludts S, Ernoux P, Chevalier D, Smetana K Jr, André S, Leroy X and Gabius HJ: Adhesion/growth-regulatory tissue lectin galectin-1 in relation to angiogenesis/lymphocyte infiltration and prognostic relevance of stromal up-regulation in laryngeal carcinomas. Anticancer Res 29: 59-66, 2009.
10. Saussez S, Decaestecker C, Manillon V, Cludts S, Capouillez A, Chevalier D, Vet HK, André S, Toubeau G, Leroy X and Gabius HJ: Galectin-3 up-regulation during tumor progression in head and neck cancer. Laryngoscope 118: 1583-1590, 2008.
11. Lahm H, André S, Hoeflich A, Fischer JR, Sordat B, Kaltner H, Wolf E and Gabius HJ: Comprehensive galectin fingerprinting in a panel of 61 human tumor cell lines by RT-PCR and its implications for diagnostic and therapeutic procedures. J Cancer Res Clin Oncol 127: 375-386, 2001.
12. Su Z-Z, Lin J, Shen R, Fisher PE, Goldstein NI and Fisher PB: Surface-epitope masking and expression cloning identifies the human prostate carcinoma tumor antigen gene PCTA-1, a member of the galectin gene family. Proc Natl Acad Sci USA 93: 7252-7257, 1996.
13. Bassen R, Brichory F, Cahlet-Maugendre S, Bidon N, Delavai P, Desrues B and Dazord L: Expression of Po66-CBP, a type-8 galectin, in different healthy, tumoral and peritumoral tissues. Anticancer Res 19: 5429-5434, 1999.
14. Hadari YR, Arbel-Goren R, Levy Y, Amsterdam A, Alon R, Zakut R and Zick Y: Galectin-8 binding to integrins inhibits cell adhesion and induces apoptosis. J Cell Sci 113: 2385-2397, 2000.
15. Danguy A, Rorive S, Decaestecker C, Bronckart Y, Kaltner H, Hadari YR, Goren R, Zich Y, Petein M, Salmon I, Gabius HJ and Kiss R: Immunohistochemical profile of galectin-8 expression in benign and malignant tumors of epithelial, mesenchymatous and adipous origins, and of the nervous system. Histol Histopathol 16: 861-868, 2001.
16. Levy Y, Arbel-Goren R, Hadari YR, Eshhar S, Ronen D, Elhanany E, Geiger B and Zick Y: Galectin-8 functions as a matricellular modulator of cell adhesion. J Biol Chem 276: 31285-31295, 2001.
17. Eshkar Sebban L, Ronen D, Levartovsky D, Elkayam O, Caspi D, Aamar S, Amital H, Rubinow A, Golan I, Naor D, Zick Y and Golan I: The involvement of CD44 and its novel ligand galectin-8 in apoptotic regulation of autoimmune inflammation. J Immunol 179: 1225-1235, 2007.
18. high thymocyte subpopulation. Glycobiology 17: 1404-1412, 2007.
19. Nishi N, Shoji H, Seki M, Itoh A, Miyanaka H, Yuube K, Hiroshima M and Nakamura T: Galectin-8 modulates neutrophil function via interaction with integrin αM. Glycobiology 13: 755-763, 2003.
20. Kaltner H, Soli's D, André S, Lensch M, Manning JC, Mürnseer M, Sáiz JL and Gabius HJ: Unique chicken tandem-repeat-type galectin: implications of alternative splicing and a distinct expression profile compared to those of the three proto-type proteins. Biochemistry 48: 4403-16, 2009.
21. Saussez S, Cludts S, Capouillez A, Mortuaire G, Smetana K Jr, Kaltner H, André S, Leroy X, Gabius HJ and Decaestecker C: Identification of matrix metalloproteinase-9 as an independent prognostic marker in laryngeal and hypopharyngeal cancer with opposite correlations to adhesion/growth-regulatory galectins 1 and 7. Int J Oncol 34: 433-439, 2009.
22. Hyams VJ, Batsakis JG and Michaels L (eds.): Tumors of the Upper Respiratory Tract and Ear. Atlas of Tumor Pathology. Washington, D.C.: Armed Forces Institute of Pathology, 1988.
23. Galle N, Pilch BZ, Sidransky D, Westra WH and Califano J: Epithelial Precursor Lesions. World Health Organization Classification of Tumours. Pathology and Genetics. Head and Neck Tumours. Lyon, France: IARC Press pp. 177-179, 2005.
24. Wittekind C, Greene FL, Hutter RVP, Klimpfinger M and Sobin LH: TNM Atlas. 5th ed. Berlin: UICC Springer, 2004.
25. André S, Pei Z, Siebert H-C, Ramström O and Gabius HJ: Glycosyldisulfides from dynamic combinatorial libraries as O-glycoside mimetics for plant and endogenous lectins: their reactivities in solid-phase and cell assays and conformational analysis by molecular dynamics simulations. Bioorg Med Chem 14: 6314-6326, 2006.
26. Wu AM, Singh T, Wu JH, Lensch M, André S and Gabíus HJ: Interaction profile of galectin-5 with free saccharides and mammalian glycoproteins: probing its fine specificity and the effect of naturally clustered ligand presentation. Glycobiology 16: 524-537, 2006.
27. Beer A, André S, Kaltner H, Lensch M, Franz S, Sarter K, Schulze C, Gaipl US, Kern P, Herrmann M and Gabius HJ: Human galectins as sensors for apoptosis/necrosis-associated surface changes of granulocytes and lymphocytes. Cytometry A 73: 139-147, 2008.
28. Kaltner H, Solís D, Kopitz J, Lohr M, Manning JC, Mürnseer M, Schnölzer M, André S, Sáiz JL and Gabius HJ: Prototype chicken galectins revisited: characterization of a third protein with distinctive hydrodynamic behaviour and expression pattern in organs of adult animals. Biochem J 409: 591-599, 2008.
29. Lensch M, Lohr M, Russwurm R, Vidal M, Kaltner H, André S and Gabius HJ: Unique sequence and expression profiles of rat galectins-5 and -9 as a result of species-specific gene divergence. Int J Biochem Cell Biol 38: 1741-1758, 2006.
30. Lohr M, Lensch M, André S, Vidal M, Kaltner H, André S and Gabius HJ: Murine homodimeric adhesion/growth-regulatory galectins-1, -2 and -7: comparative profiling of gene/promoter sequences by database mining, of expression by RT-PCR/immunohistochemistry and of contact sites for carbohydrate ligands by computational chemistry. Folia Biol (Praha) 53: 109-128, 2006.
31. Lahm H, André S, Hoeflich A, Kaltner H, Siebert HC, Sordat B, von der Lieth CW, Wolf E and Gabius HJ: Tumor galectinology: insights into the complex network of a family of endogenous lectins. Glycoconj J 20: 227-238, 2004.
32. Hirabayashi J, Hashidate T, Arata Y, Nishi N, Nakamura T, Hirashima M, Urashima T, Oka T, Futai M, Muller WE, Yagi F and Kasai K: Oligosaccharide specificity of galectins: a search by frontal affinity chromatography. Biochim Biophys Acta 1572: 232-254, 2002.
33. Ideo H, Seko A, Ishizuka I and Yamashita K: The N-terminal carbohydrate recognition domain of galectin-8 recognizes specific glycosphingolipids with high affinity. Glycobiology 13: 713-723, 2003.
34. Stowell SR, Arthur CM, Slanina KA, Horton JR, Smith DF and Cummings RD: Dimeric galectin-8 induces phosphatidylserine exposure in leukocytes through polylactosamine recognition by the C-terminal domain. J Biol Chem 283: 20547-2059, 2008.
35. Cárcamo C, Pardo E, Oyanadel C, Bravo-Zehnder M, Bull P, Cáceres M, Martinez J, Massardo L, Jacobelli S, González A and Soza A: Galectin-8 binds specific β1 integrins and induces polarized spreading highlighted by asymmetric lamellipodia in Jurkat T-cells. Exp Cell Res 312: 374-386, 2006.
36. Diskin S, Cao Z, Leffler H and Panjwani N: The role of integrin glycosylation in galectin-8-mediated trabecular meshwork cell adhesion and spreading. Glycobiology 19: 29-37, 2009.
37. Massardo L, Metz C, Pardo E, Mezzano V, Babul M, Jarpa E, Guzmán AM, André S, Kaltner H, Gabius HJ, Jacobelli S, González A and Soza A: Autoantibodies against galectin-8: their specificity, association with lymphopenia in systemic lupus erythematosus and detection in rheumatoid arthritis and acute inflammation. Lupus 18: 539-546, 2009.
38. Lu H, Knutson KL, Gad E and Disis ML: The tumor antigen repertoire identified in tumor-bearing neu transgenic mice predicts human tumor antigens. Cancer Res 66: 9754-9761, 2006.
39. Caulet-Maugendre S, Birolleau S, Corbineau H, Bassen R, Desrues B, Bidon N, Delaval P, Ramée MP, Brichory F and Dazord L: Immunohistochemical expression of the intracellular component of galectin-8 in squamous cell metaplasia of the bronchial epithelium in neoplastic and benign processes. Pathol Res Pract 197: 797-801, 2001.
40. Henno S, Brichory F, Langanay T, Desrues B, Bidon N, Delaval P, Ramee MP, Dazord L and Caulet-Maugendre S: Expression of Po66-CBP, a galectin-8, in different types of primary and secondary broncho-pulmonary tumors. Oncol Rep 9: 177-180, 2002.
41. Kayser K, Trott J, Böhm G, Huber M, Kaltner H, André S and Gabius HJ: Localized fibrous tumors (LFTs) of the pleura: clinical data, asbestos burden, and syntactic structure analysis applied to newly defined angiogenic/growth-regulatory effectors. Pathol Res Pract 201: 791-801, 2005.
42. Sheikholeslam-Zadeh R, Decaestecker C, Delbrouck C, Danguy A, Salmon I, Zick Y, Kaltner H, Hassid S, Gabius HJ, Kiss R and Choufani G: The levels of expression of galectin-3, but not of galectin-1 and galectin-8, correlate with apoptosis in human cholesteatomas. Laryngoscope 111: 1042-1047, 2001.
43. Nagy N, Bronckart Y, Camby I, Legendre H, Lahm H, Kaltner H, Hadari Y, Van Ham P, Yeaton P, Pector JC, Zick Y, Salmon I, Danguy A, Kiss R and Gabius HJ: Galectin-8 expression decreases in cancer compared with normal and dysplastic human colon tissue and acts significantly on human colon cancer cell migration as a suppressor. Gut 50: 392-401, 2002.
44. Kayser K, Hoeft D, Hufnagl P, Caselitz J, Zick Y, André S, Kaltner H and Gabius HJ: Combined analysis of tumor growth pattern and expression of endogenous lectins as a prognostic tool in primary testicular cancer and its lung metastases. Histol Histopathol 18: 771-779, 2003.
45. Nagy N, Legendre H, Engels O, André S, Kaltner H, Wasano K, Zick Y, Pector JC, Decaestecker C, Gabius HJ, Salmon I and Kiss R: Refined prognostic evaluation in colon carcinoma using immunohistochemical galectin fingerprinting. Cancer 97: 1849-1858, 2003.
46. Langbein S, Brade J, Badawi JK, Hatzinger M, Kaltner H, Lensch M, Specht K, André S, Brinck U, Alken P and Gabius HJ: Gene-expression signature of adhesion/growth-regulatory tissue lectins (galectins) in transitional cell cancer and its prognostic relevance. Histopathology 51: 681-690, 2007.